\name{print.threep3}
\alias{print.threep3}
\title{
Print information regarding the operating characteristics of a standard 3+3 design
}
\description{
Print method for a 3+3 design specified using a \code{\link{threep3}}. 
}
\usage{
\method{print}{threep3}(x, tox.cutpoints = NULL, dose = NULL, \ldots)
}
\arguments{
  \item{x}{
An object of class "threep3" as returned by \code{\link{threep3}}
}
 \item{tox.cutpoints}{
An optional argument passed to \code{print.threep3} specifying the cutpoints of toxicity for which the operating characteristics are to be categorised. Defaults to \code{seq(from=0,to=1,by=0.2)}
}
 \item{dose}{Optional vector of length \code{k} of actual doses for presentation purposes
}
 \item{...}{Further arguments passed to or from other methods}
}
\details{
The following operating characteristics are printed for the standard 3+3 design:
\describe{
	\item{Sample size}{Mean, minimum and maximum sample size of the design}
	\item{Experimentation proportion}{Proportion of patients recruited to each dose, and to each true region of toxicity, on average}
	\item{Recommendation proportion}{Proportion of 3+3 trials that would recommend each of the dose levels as the final maximum tolerated dose (see \code{\link{threep3}} for definition of the MTD), and the associated regions of true toxicity for the recommended MTDs}
	\item{Average number of patients}{The average number of patients dosed at each level}
	\item{Average number of DLTs}{The average number of DLTs seen at each level}
}
}


\author{
Michael Sweeting \email{mjs212@medschl.cam.ac.uk} (University of Cambridge, UK)
}
\references{
 Sweeting M., Mander A., Sabin T. \pkg{bcrm}: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials. \emph{Journal of Statistical Software} (2013) 54: 1--26. \url{http://www.jstatsoft.org/article/view/v054i13}
}
\seealso{
\code{\link{threep3}}
}
